Publicaciones en colaboración con investigadores/as de University of Sydney (16)

2024

  1. Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522

    Annals of Oncology

2023

  1. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

    Respiratory Research, Vol. 24, Núm. 1

2022

  1. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

    New England Journal of Medicine, Vol. 386, Núm. 6, pp. 556-567

2021

  1. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2020

  1. Epilepsy and Electroencephalographic Abnormalities in SATB2-Associated Syndrome

    Pediatric Neurology, Vol. 112, pp. 94-100

  2. Lucitanib for the treatment of HRþ/HER2- Metastatic breast cancer: Results from the multicohort phase II FINESSE study

    Clinical Cancer Research, Vol. 26, Núm. 2, pp. 354-363

  3. Pembrolizumab for early triple-negative breast cancer

    New England Journal of Medicine, Vol. 382, Núm. 9, pp. 810-821

2019

  1. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study

    Annals of Oncology, Vol. 30, Núm. 3, pp. 397-404

2015

  1. Effects of the economic crisis and social support on health-related quality of life: First wave of a longitudinal study in Spain

    British Journal of General Practice, Vol. 65, Núm. 632, pp. e198-e203

2014

  1. Barriers and facilitators for the implementation of primary prevention and health promotion activities in primary care: A synthesis through meta-ethnography

    PLoS ONE, Vol. 9, Núm. 2

  2. Patients' opinions about knowing their risk for depression and what to do about it. The predictD-qualitative study

    PLoS ONE, Vol. 9, Núm. 3

  3. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: The neuromodulation appropriateness consensus committee

    Neuromodulation, Vol. 17, Núm. 6, pp. 515-550

2013

  1. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

    Brain, Vol. 136, Núm. 6, pp. 1778-1782

  2. Preventing the onset of major depression based on the level and profile of risk of primary care attendees: Protocol of a cluster randomised trial (the predictD-CCRT study)

    BMC Psychiatry, Vol. 13

2004

  1. Noninvasive ventilation [1] (multiple letters)

    New England Journal of Medicine

2002

  1. Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial

    Journal of the National Cancer Institute, Vol. 94, Núm. 14, pp. 1054-1065